Thiol regulation of the production of TNF-α, IL-6 and IL-8 by human alveolar macrophages

Reactive oxygen intermediates exert signalling functions and modulate gene transcription, particularly for pro-inflammatory cytokines. Since exogenous as well as endogenous thiols could be potent inhibitors of the production of cytokines, the effects of N-acetylcysteine (NAC), glutathione (GSH) and modulated GSH synthesis on the production of tumour necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-8 by human alveolar macrophages (AMs) was evaluated, as well as the potential role of intracellular GSH depletion on the effect of exogenous thiols. AMs were stimulated with lipopolysaccharide (LPS) and cytokine production was measured by evaluating messenger ribonucleic acid (mRNA) expression and protein secretion. Depletion of intracellular GSH by treatment with buthionine sulphoximine (BSO) reached 45.2% after 3 h and was nearly complete at 24 h. Whereas a 24-h preincubation of AMs with BSO significantly increased LPS-induced secretion of TNF-alpha and IL-8, a 3-h preincubation only enhanced LPS-stimulated production of IL-8 (p<0.05). Treatment with NAC and GSH did not significantly increase intracellular content of GSH even after a 48-h incubation. Addition of GSH and NAC significantly reduced the secretion of TNF-alpha (mean+/-SEM 21.2+/-5 and 44.7+/-4.4% inhibition, respectively) as well as LPS-induced IL-6 and IL-8 (p<0.05). Similarly, NAC inhibited the production of TNF-alpha, IL-6 and IL-8 in GSH-depleted AMs obtained by BSO pretreatment. In conclusion, N-acetylcysteine and glutathione inhibit the production of tumour necrosis factor-alpha, interleukin-8 and interleukin-6 by alveolar macrophages by a mechanism independent of glutathione metabolism. However, total depletion of glutathione within alveolar macrophages significantly increases tumour necrosis factor-alpha and interleukin-8 synthesis whereas it does not modulate interleukin-6 secretion.

[1]  K. Douglas,et al.  Mechanism of action of glutathione-dependent enzymes. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  C. Sen.  Redox signaling and the emerging therapeutic potential of thiol antioxidants. , 1998, Biochemical pharmacology.

[3]  M. Kitamura,et al.  c-Jun/AP-1, but not NF-kappa B, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells. , 1997, Biochemical and biophysical research communications.

[4]  E. Conner,et al.  Oxidant-regulation of gene expression in the chronically inflamed intestine. , 1997, The Keio journal of medicine.

[5]  E. S. Fox,et al.  Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. , 1996, The Biochemical journal.

[6]  M. Baggiolini,et al.  Interleukin-8 and the chemokine family. , 1995, International journal of immunopharmacology.

[7]  J. Remacle,et al.  Low levels of reactive oxygen species as modulators of cell function. , 1995, Mutation research.

[8]  S. Lebègue,et al.  Protective role of glutathione on α1 proteinase inhibitor inactivation by the myeloperoxidase system. Hypothetic study for therapeutic strategy in the management of smokers' emphysema , 1994, Fundamental & clinical pharmacology.

[9]  K. Schulze-Osthoff,et al.  Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Allison,et al.  Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-α, IL-β, and IL-6 by human peripheral blood mononuclear cells , 1994 .

[11]  R. Bone,et al.  Role of tumor necrosis factor-α in disease states and inflammation , 1993 .

[12]  A. Tamir,et al.  N-acetylcysteine delays the infiltration of inflammatory cells into the lungs of paraquat-intoxicated rats. , 1993, Toxicology and applied pharmacology.

[13]  R. Faggioni,et al.  Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide‐induced pulmonary oedema and lethality , 1993, Clinical and experimental immunology.

[14]  B. Wallaert,et al.  In vitro effects of hyperoxia on alveolar type II pneumocytes: inhibition of glutathione synthesis increases hyperoxic cell injury. , 1992, Experimental lung research.

[15]  D. Remick,et al.  Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. , 1992, The Journal of clinical investigation.

[16]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[17]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[18]  A. Mantovani,et al.  N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. , 1992, Cellular immunology.

[19]  B. Wallaert,et al.  Production of tumor necrosis factor-alpha and interleukin-6 by human alveolar macrophages exposed in vitro to coal mine dust. , 1991, American Journal of Respiratory Cell and Molecular Biology.

[20]  G. Bernard,et al.  N-acetylcysteine in experimental and clinical acute lung injury. , 1991, The American journal of medicine.

[21]  R. Crystal,et al.  Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis , 1991, The Lancet.

[22]  R. Strieter,et al.  Tumor Necrosis Factor–Alpha Gene Expression in Human Whole Blood , 1990, Journal of leukocyte biology.

[23]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[24]  I. Clark,et al.  Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. , 1989, Journal of immunology.

[25]  A. Kharazmi,et al.  Effect of oral N‐acetylcysteine administration on human blood neutrophil and monocyte function , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[26]  C. Uyttenhove,et al.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Bernard,et al.  Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. , 1984, The Journal of clinical investigation.

[28]  G. Gifford,et al.  Rabbit tumor necrosis factor: mechanism of action , 1981, Infection and immunity.

[29]  O. Griffith,et al.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. , 1980, Analytical biochemistry.

[30]  G. Poli,et al.  Oxidative damage and fibrogenesis. , 1997, Free radical biology & medicine.

[31]  G. Poli,et al.  Biogenic 4‐hydroxy‐2‐nonenal activates transcription factor AP‐1 but not NF‐κB in cells of the macrophage lineage , 1997, BioFactors.

[32]  O. Aruoma,et al.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. , 1989, Free radical biology & medicine.